Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Scroll down and select country
MEBO TMAU TESTING CURRENTLY SUSPENDED INDEFINITELY

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

London TMAU meeting with Prof Liz Shephard
19th Oct 11am - 1pm
St Mary's Hospital
Praed St, Paddington
London W2 1NY
click to read more
more details : karen.james@meboresearch.org

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Wednesday, August 24, 2016

Raising Awareness in India

PLEASE SIGN PETITION CREATED
BY A SUFFERER FROM INDIA



get New Posts by EMAIL : Enter your email address :



A EURORDIS and NORD Member Organization

3 comments:

Anonymous said...

I wish that any research labs that have a potential cure sitting around would offer it to this rare disease community in some fashion. Recently, I learned that the Cleveland Heart Lab has DMB formulations patented that would help the TMAU community, but chose not to use it just now. So, as they're sitting on a patent,
it may be hard for other researchers to use that knowledge for our benefit.

I know it's good manners to be patient and passive with research labs, but gosh darn it, I wonder if they are aware of the enormous need out there.

Aug 29, 2016, 6:20:00 PM
blogcontributor2 said...

Cleveland Clinic are working on a TMA blocker pill. We don't know how long it will take. It will be an over-the-counter pill made by P&G. They won't be using DMB as they will be using something stronger. DMB is a natural compound so can't be patented.

So you can be safe in knowing that work is going ahead on a tma-blocker pill and it will come to market as it is for heart disease protection.

Aug 29, 2016, 7:21:00 PM
Anonymous said...

Actually, there is a patent, not for DMB itself , but for the discovery that DMB will block the formation of TMAO. It is viewable online.

Aug 31, 2016, 1:48:00 AM
Post a Comment